Advancements in Angiogenic Biomarkers for Preeclampsia

This chapter explores the complexities of preeclampsia, particularly the impact of angiogenic biomarkers on its prediction and diagnosis. It covers the recent FDA approval of the S-FLIT ratio test, the available testing options for practitioners, and the need for equitable access across medical centers while adhering to FDA guidelines.